Influence of type of starch and feeding management

Affect of kind of starch and feeding administration on glycaemic management in diabetic canine

  • The current research evaluated the consequences of two diets with completely different starch sources and two feeding strategies on the glycaemic management in canine with diabetes mellitus. The diets had related nutrient contents (40% starch and 16% dietary fibre), one formulated with 46% of damaged rice and the opposite with 42% sorghum and 10% lentils (as-fed).
  • Ten client-owned diabetic canine had been fed with every weight loss plan for two months, in a crossover design. 5 canine obtained NPH human insulin and meals each 12 h (feeding technique 1), and the opposite 5 obtained insulin each 12 h however had been fed 3 times a day (feeding technique 2). In feeding technique 2, morning insulin was larger than the night dose and canine obtained the second meal after Four to five h of the morning insulin and meal.
  • Parameters evaluated included insulin dosage, 12- and 8-h glycaemic curves, full blood rely, biochemical profile and urinalysis. Glycaemic curves had been analysed by ANOVA with repeated measures. Glycaemic management parameters (fasting, imply, minimal and most glycaemia and serum fructosamine) and glucose space underneath the curve (AUC) had been calculated and analysed by paired t check (p < 0.05). In feeding technique 1, canine fed the sorghum-based weight loss plan offered decrease imply (p = 0.04) and minimal blood glucose concentrations (p = 0.03), and an inclination to decrease most blood glucose (p = 0.06) and glucose AUC (p = 0.08) than when fed the rice-based weight loss plan.
  • When meals was offered twice a day, the ingestion of the rice-based weight loss plan resulted in larger post-prandial glucose response than the weight loss plan with sorghum and lentil. In feeding technique 2, there was no impact of weight loss plan on the assessed parameters (p > 0.05).
  • No variations in insulin dosage had been noticed between teams or feeding strategies (p > 0.05). Offering two meals a day adopted by insulin administration related to the sorghum- and lentil-based weight loss plan improved glycaemic management in diabetic canine.
insuline-medical
insuline-medical

Rrad/ Rat Rrad ELISA Kit

ELI-14921r 96 Tests
EUR 1063.2

Polyclonal RRAD Antibody

APR05556G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications:

RRAD Conjugated Antibody

C37229 100ul
EUR 476.4

RRAD Peptide

43-008P 0.1 mg
EUR 405.6
Description: RRAD Peptide

RRAD siRNA

20-abx932133
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

RRAD Blocking Peptide

33R-10070 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798

RRAD Blocking Peptide

33R-4793 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797

RRAD Blocking Peptide

20-abx063234
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

Anti-RRAD (aa36-48) antibody

STJ72757 100 µg
EUR 430.8

Human RRAD shRNA Plasmid

20-abx954199
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

RRAD ELISA KIT|Human

EF005507 96 Tests
EUR 826.8

RRAD Recombinant Protein (Rat)

RP226925 100 ug Ask for price

RRAD Recombinant Protein (Human)

RP095493 100 ug Ask for price

RRAD Recombinant Protein (Mouse)

RP169340 100 ug Ask for price

GTP-Binding Protein RAD (RRAD) Antibody

20-abx008742
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

GTP-binding protein RAD (RRAD) Antibody

abx332370-100ul 100 ul
EUR 510

GTP-binding protein RAD (RRAD) Antibody

20-abx241706
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

GTP-binding protein RAD (RRAD) Antibody

20-abx324872
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

GTP-Binding Protein RAD (RRAD) Antibody

abx432011-200ul 200 ul
EUR 460.8

GTP-binding protein RAD (RRAD) Antibody

20-abx214509
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Polyclonal RRAD (aa36-48) Antibody (internal region)

APG00807G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human RRAD (aa36-48) (internal region). This antibody is tested and proven to work in the following applications:

Rrad ORF Vector (Rat) (pORF)

ORF075643 1.0 ug DNA
EUR 607.2

Rrad ORF Vector (Mouse) (pORF)

ORF056448 1.0 ug DNA
EUR 607.2

RRAD ORF Vector (Human) (pORF)

ORF031832 1.0 ug DNA
EUR 486

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx122938-100ug 100 ug
EUR 469.2

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx237237-100ug 100 ug
EUR 661.2

RRAD sgRNA CRISPR Lentivector set (Human)

K2069901 3 x 1.0 ug
EUR 406.8

Rrad sgRNA CRISPR Lentivector set (Rat)

K7052701 3 x 1.0 ug
EUR 406.8

Rrad sgRNA CRISPR Lentivector set (Mouse)

K3480701 3 x 1.0 ug
EUR 406.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 1)

K2069902 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 2)

K2069903 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 3)

K2069904 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Rat) (Target 1)

K7052702 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Rat) (Target 2)

K7052703 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Rat) (Target 3)

K7052704 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3480702 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3480703 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3480704 1.0 ug DNA
EUR 184.8

RRAD Protein Vector (Human) (pPB-C-His)

PV127326 500 ng
EUR 662.4

RRAD Protein Vector (Human) (pPB-N-His)

PV127327 500 ng
EUR 662.4

RRAD Protein Vector (Human) (pPM-C-HA)

PV127328 500 ng
EUR 662.4

RRAD Protein Vector (Human) (pPM-C-His)

PV127329 500 ng
EUR 662.4

RRAD Protein Vector (Mouse) (pPB-C-His)

PV225790 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPB-N-His)

PV225791 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPM-C-HA)

PV225792 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPM-C-His)

PV225793 500 ng
EUR 723.6

Rrad 3'UTR GFP Stable Cell Line

TU269725 1.0 ml Ask for price

RRAD 3'UTR Luciferase Stable Cell Line

TU022380 1.0 ml
EUR 1672.8

Rrad 3'UTR Luciferase Stable Cell Line

TU219725 1.0 ml Ask for price

RRAD 3'UTR GFP Stable Cell Line

TU072380 1.0 ml
EUR 1672.8

Rrad 3'UTR GFP Stable Cell Line

TU168183 1.0 ml Ask for price

RRAD Protein Vector (Rat) (pPB-C-His)

PV302570 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPB-N-His)

PV302571 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPM-C-HA)

PV302572 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPM-C-His)

PV302573 500 ng
EUR 723.6

Rrad 3'UTR Luciferase Stable Cell Line

TU118183 1.0 ml Ask for price

Human GTP-binding protein RAD (RRAD) ELISA Kit

abx385354-96tests 96 tests
EUR 1093.2

Mouse GTP-binding protein RAD (RRAD) ELISA Kit

abx390415-96tests 96 tests
EUR 1093.2

Rat GTP-binding protein RAD (RRAD) ELISA Kit

abx391893-96tests 96 tests
EUR 1093.2

Human GTP- binding protein RAD, RRAD ELISA KIT

ELI-35549h 96 Tests
EUR 988.8

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV658369 1.0 ug DNA
EUR 616.8

RRAD Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV658373 1.0 ug DNA
EUR 616.8

RRAD Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV658374 1.0 ug DNA
EUR 616.8

Mouse GTP- binding protein RAD, Rrad ELISA KIT

ELI-14089m 96 Tests
EUR 1038

Human RRAD And GEM Like GTPase 2 (REM2) ELISA Kit

abx382769-96tests 96 tests
EUR 1093.2

Rrad ELISA Kit| Mouse GTP-binding protein RAD ELISA Kit

EF016057 96 Tests
EUR 826.8

Rrad ELISA Kit| Rat GTP-binding protein RAD ELISA Kit

EF019253 96 Tests
EUR 826.8

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K2069905 3 x 1.0 ug
EUR 451.2

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K7052705 3 x 1.0 ug
EUR 451.2

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3480705 3 x 1.0 ug
EUR 451.2

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K2069906 1.0 ug DNA
EUR 200.4

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K2069907 1.0 ug DNA
EUR 200.4

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K2069908 1.0 ug DNA
EUR 200.4

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV658370 1.0 ug DNA
EUR 616.8

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV658371 1.0 ug DNA
EUR 686.4

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV658372 1.0 ug DNA
EUR 686.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K7052706 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K7052707 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K7052708 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3480706 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3480707 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3480708 1.0 ug DNA
EUR 200.4

Positive control tissue section for each individua

Control-Slides-for-each-antibody Set of 25
EUR 355
Description: Positive control tissue section for each individual antibody; Based on availability; INQUIRE

CD11b Antibody Antibody

ABD2911 100 ug
EUR 525.6

ASAP1 antibody Antibody

DF8746 200ul
EUR 420

anti- Antibody^Polyclonal antibody control antibody

LSMab09882 100 ug
EUR 525.6

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.08ML 0.08 ml
EUR 165

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.4ML 0.4 ml
EUR 379

Antibody

A1360-500 each Ask for price

Anti-Glycolipid Antibody (AGA) Antibody

20-abx004855
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Ly1 Antibody Reactive (LYAR) Antibody

20-abx008109
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Ly1 Antibody Reactive (LYAR) Antibody

20-abx123734
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

Ly1 Antibody Reactive (LYAR) Antibody

20-abx014333
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Ly1 Antibody Reactive (LYAR) Antibody

abx033330-400ul 400 ul
EUR 627.6

Ly1 Antibody Reactive (LYAR) Antibody

abx033330-80l 80 µl
EUR 343.2

Anti-Glycolipid Antibody (AGA) Antibody

abx036399-100ug 100 ug
EUR 469.2

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319900
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319901
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319905
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319913
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycolipid Antibody (AGA) Antibody

abx230204-100ug 100 ug
EUR 577.2

Ly1 Antibody Reactive (LYAR) Antibody

20-abx324434
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Ly1 Antibody Reactive (LYAR) Antibody

20-abx311665
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Ly1 Antibody Reactive (LYAR) Antibody

abx234901-100ug 100 ug
EUR 661.2

Anti-Anti-SEPT6 antibody antibody

STJ11100949 100 µl
EUR 332.4
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined.

Anti-Anti-SEPT9 Antibody antibody

STJ111369 100 µl
EUR 332.4
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.

Anti-Anti-SEPT11 Antibody antibody

STJ111530 100 µl
EUR 332.4

Anti-Anti-SEPT4 Antibody antibody

STJ112276 100 µl
EUR 332.4
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer.

Anti-Anti-MARCH9 Antibody antibody

STJ112609 100 µl
EUR 332.4

Anti-Anti-SEPT11 Antibody antibody

STJ113941 100 µl
EUR 332.4

Associations between attainment of incentivized main care indicators and incident decrease limb amputation amongst these with kind 2 diabetes: a population-based historic cohort research

Introduction: England has invested significantly in diabetes care by way of such packages because the High quality and Outcomes Framework (QOF) and Nationwide Diabetes Audit (NDA). Associations between program indicators and scientific endpoints, similar to amputation, stay unclear. We examined associations between main care indicators and incident decrease limb amputation.

Analysis design and strategies: This population-based retrospective cohort research, spanning 2010-2017, was comprised of adults in England with kind 2 diabetes and no historical past of decrease limb amputation. Exposures at baseline (2010-2011) had been attainment of QOF glycated hemoglobin (HbA1c), blood stress and whole ldl cholesterol indicators, and variety of NDA processes accomplished.

Propensity rating matching was carried out and multivariable Cox proportional hazards fashions, adjusting for disease-related, comorbidity, way of life, and sociodemographic elements, had been fitted utilizing matched samples for every publicity.

Outcomes: 83 688 people from 330 English main care practices had been included. Imply follow-up was 3.9 (SD 2.0) years, and 521 (0.6%) minor or main amputations had been noticed (1.62 per 1000 person-years). HbA1c and ldl cholesterol indicator attainment had been related to significantly decrease dangers of minor or main amputation (adjusted HRs; 95% CIs) 0.61 (0.49 to 0.74; p<0.0001) and 0.67 (0.53 to 0.86; p=0.0017), respectively). No proof of affiliation between blood stress indicator attainment and amputation was noticed (adjusted HR 0.88 (0.73 to 1.06; p=0.1891)).

Considerably decrease amputation charges had been noticed amongst these finishing a larger variety of NDA care processes (adjusted HRs 0.45 (0.24 to 0.83; p=0.0106), 0.67 (0.47 to 0.97; p=0.0319), and 0.38 (0.20 to 0.70; p=0.0022) for comparisons of 4-6 vs 0-3, 7-9 vs 0-3, and 7-9 vs 4-6 processes, respectively). Outcomes for major-only amputations had been related for HbA1c and blood stress, although ldl cholesterol indicator attainment was non-significant.

Conclusions: Complete main care-based secondary prevention might supply appreciable safety in opposition to diabetes-related amputation. This has necessary implications for diabetes administration and medical decision-making for sufferers, in addition to kind 2 diabetes high quality enchancment packages.

 

The pattern-recognition molecule H-ficolin in relation to diabetic kidney illness, mortality, and cardiovascular occasions in kind 1 diabetes

H-ficolin acknowledges patterns on microorganisms and burdened cells and may activate the lectin pathway of the complement system. We aimed to evaluate H-ficolin in relation to the development of diabetic kidney illness (DKD), all-cause mortality, diabetes-related mortality, and cardiovascular occasions.

Occasion charges per 10-unit H-ficolin-increase had been in contrast in an observational follow-up of two,410 people with kind 1 diabetes from the FinnDiane Research. DKD development occurred in 400 people. The unadjusted hazard ratio (HR) for development was 1.29 (1.18-1.40) and 1.16 (1.05-1.29) after adjustment for diabetes length, intercourse, HbA1c, systolic blood stress, and smoking standing.

After including triglycerides to the mannequin, the HR decreased to 1.07 (0.97-1.18). In all, 486 people died, together with 268 deaths of cardiovascular causes and 192 deaths of problems to diabetes. HRs for all-cause mortality and cardiovascular mortality had been 1.13 (1.04-1.22) and 1.05 (0.93-1.17), respectively, in unadjusted analyses. These estimates misplaced statistical significance in adjusted fashions.

Nevertheless, the unadjusted HR for diabetes-related mortality was 1.19 (1.05-1.35) and 1.18 (1.02-1.37) with probably the most stringent adjustment stage. Our outcomes, due to this fact, point out that H-ficolin predicts diabetes-related mortality, however neither all-cause mortality nor deadly/non-fatal cardiovascular occasions. Moreover, H-ficolin is related to DKD development, nevertheless, not independently of the totally adjusted mannequin.

The worth of glycosylated hemoglobin within the prognosis of diabetic retinopathy: a scientific evaluate and Meta-analysis

 Goal: Glycosylated hemoglobin (HbA1c) has apparent scientific worth within the prognosis of diabetes, however the conclusions on the diagnostic worth of diabetic retinopathy (DR) should not constant. This research goals to comprehensively consider the accuracy of glycosylated hemoglobin within the prognosis of diabetic retinopathy by way of the meta-analysis of diagnostic checks.

Strategies: Cochrane Library, Embase, PubMed, Net of Science, China Nationwide Information Infrastructure (CNKI), China Wanfang Database, Chinese language Biomedical Literature Database (CBM) had been searched till November, 2020. The High quality Evaluation of Diagnostic Accuracy Research-2 (QUADAS-2) software was used to evaluate the standard of the included research. The pooled sensitivity, specificity, optimistic probability ratio (+LR), unfavourable probability ratio (-LR), diagnostic odds ratio (DOR) and areas underneath the receiver working attribute (ROC) curve had been calculated by Stata 15.Zero software program.

Outcomes: After screening, 18 high-quality papers had been included. The outcomes of meta-analysis confirmed that the mixed DOR = 18.19 (95% CI: 10.99-30.11), the sensitivity= 0.81 (95% CI): 0.75 ~ 0.87), specificity = 0.81 (95%CI: 0.72 ~ 0.87), +LR = 4.2 (95%CI: 2.95 ~ 6.00), -LR = 0.23 (95%CI: 0.17 ~ 0.31), and the world underneath the Abstract ROC curve was 0.88 (95%CI: 0.85 ~ 0.90).

Conclusion: The general accuracy of HbA1cC forin diagnosing diabetic retinopathy is sweet. As it’s extra secure than blood sugar and isn’t affected by meals, it might be an acceptable indicator for diabetic retinopathy.

ExoStd? Lyophilized Exosome Standard (30 µg, COLO1 cell line, 2 vials)

M1048-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, COLO1 cell line, 2 vials)

M1049-2 each
EUR 861.6

ExoStd? Lyophilized Exosome Standard (30 µg, MM1 cell line, 2 vials)

M1050-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, MM1 cell line, 2 vials)

M1051-2 each
EUR 861.6

ExoStd? Lyophilized Exosome Standard (30 µg, BLCL21 cell line, 2 vials)

M1052-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, BLCL21 cell line, 2 vials)

M1053-2 each
EUR 861.6

ExoStd? Lyophilized Exosome Standard (30 µg, HCT116 cell line, 2 vials)

M1058-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, HCT116 cell line, 2 vials)

M1059-2 each
EUR 861.6

ExoStd? Lyophilized Exosome Standard (30 µg, PC3 cell line, 2 vials)

M1060-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, PC3 cell line, 2 vials)

M1061-2 each
EUR 861.6

ExoStd? Lyophilized Exosome Standard (30 µg, DAUD1 cell line, 2 vials)

M1064-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, DAUD1 cell line, 2 vials)

M1065-2 each
EUR 861.6

ExoStd? Lyophilized Exosome Standard (30 µg, A549 cell line, 2 vials)

M1066-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, A549 cell line, 2 vials)

M1067-2 each
EUR 861.6

ExoStd? Lyophilized Exosome Standard (30 µg, B16F10 cell line, 2 vials)

M1070-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, B16F10 cell line, 2 vials)

M1071-2 each
EUR 861.6

ExoStd? Lyophilized Exosome Standard (30 µg, BPH-1 cell line, 2 vials)

M1062-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, BPH-1 cell line, 2 vials)

M1063-2 each
EUR 861.6

ExoStd? Lyophilized Exosome Standard (30 µg, K-562 cell line, 2 vials)

M1068-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, K-562 cell line, 2 vials)

M1069-2 each
EUR 861.6

SARS-CoV-2 Nucleocapsid Protein, Avi-His-tag

E80027
  • EUR 635.80
  • EUR 4087.60
  • 1 ml
  • 100 ul

Recombinant SARS-CoV-2 Spike Glycoprotein(S) (D614G), Partial

E80028
  • EUR 388.30
  • EUR 860.20
  • 20 ul
  • 100 ul

SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag

E80024
  • EUR 635.80
  • EUR 4995.10
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion

E80026
  • EUR 588.50
  • EUR 823.90
  • 20 ul
  • 50 ul

ExoStd? Lyophilized Exosome Standard (30 µg, SK-N-SH cell line, 2 vials)

M1056-2 each
EUR 724.8

ExoStd? Lyophilized Exosome Standard (100 µg, SK-N-SH cell line, 2 vials)

M1057-2 each
EUR 861.6

SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag

E80021
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 RBD (V367F) Protein, Avi-His-tag

E80023
  • EUR 635.80
  • EUR 3934.70
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag

E80020
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag

E80022
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 RBD Protein, Human Fc-Fusion, Avi-Tag

E80025
  • EUR 635.80
  • EUR 3934.70
  • 100 ul
  • 1 ml

Recombinant Transmembrane Protease Serine 2 Protein, Partial

E80016
  • EUR 470.80
  • EUR 753.50
  • EUR 1824.90
  • 20 ul
  • 100 ul
  • 500 ul

Exosome Component 2 (EXOSC2) Antibody

20-abx003412
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

Exosome Component 2 (EXOSC2) Antibody

20-abx125830
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Exosome Component 2 (EXOSC2) Antibody

20-abx112411
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Exosome Component 2 (EXOSC2) Antibody

abx034983-400ul 400 ul
EUR 627.6

Exosome Component 2 (EXOSC2) Antibody

abx034983-80l 80 µl
EUR 343.2

Exosome Component 2 (EXOSC2) Antibody

abx232901-100ug 100 ug
EUR 577.2

Exosome Component 2 (EXOSC2) Antibody

abx232902-100ug 100 ug
EUR 661.2

Exosome Component 2 (EXOSC2) Antibody

20-abx172308
  • EUR 1028.40
  • EUR 526.80
  • 1 mg
  • 200 ug

Exosome Component 2 (EXOSC2) Antibody

20-abx176346
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

TNFR2 Tumor Necrosis Factor Receptor Type 2 Human Recombinant Protein

PROTP20333-2 Regular: 20ug
EUR 380.4
Description: TNFR2 Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing 184 amino acids and having a molecular mass of 20kDa. The TNFR2 is purified by proprietary chromatographic techniques.

ACE2, His-Tag Protein

E80019
  • EUR 612.70
  • EUR 1437.70
  • 20 ul
  • 100 ul

Human Exosome Component 2 (EXOSC2) Protein

20-abx653328
  • EUR 693.60
  • EUR 309.60
  • EUR 2064.00
  • EUR 828.00
  • EUR 510.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Exosome Component 2 (EXOSC2)ELISA Kit

201-12-2689 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

20-abx151457
  • EUR 8853.60
  • EUR 4719.60
  • EUR 1093.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Exosome Component 2 (EXOSC2) CLIA Kit

20-abx495555
  • EUR 9567.60
  • EUR 5095.20
  • EUR 1177.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Exosome Component 2 (EXOSC2) ELISA Kit

DLR-EXOSC2-Hu-48T 48T
EUR 620.4
Description: A sandwich quantitative ELISA assay kit for detection of Human Exosome Component 2 (EXOSC2) in samples from tissue homogenates, cell lysates or other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

DLR-EXOSC2-Hu-96T 96T
EUR 807.6
Description: A sandwich quantitative ELISA assay kit for detection of Human Exosome Component 2 (EXOSC2) in samples from tissue homogenates, cell lysates or other biological fluids.

Exosome Component 2 (EXOSC2) Polyclonal Antibody (Human)

4-PAH822Hu01
  • EUR 296.40
  • EUR 3012.00
  • EUR 750.00
  • EUR 372.00
  • EUR 256.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Exosome Component 2 (EXOSC2)

Human Exosome Component 2 (EXOSC2) ELISA Kit

SEH822Hu-10x96wellstestplate 10x96-wells test plate
EUR 5677.8
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Exosome Component 2 (EXOSC2) in Tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

SEH822Hu-1x48wellstestplate 1x48-wells test plate
EUR 572.76
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Exosome Component 2 (EXOSC2) in Tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

SEH822Hu-1x96wellstestplate 1x96-wells test plate
EUR 766.8
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Exosome Component 2 (EXOSC2) in Tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

SEH822Hu-5x96wellstestplate 5x96-wells test plate
EUR 3090.6
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Exosome Component 2 (EXOSC2) in Tissue homogenates, cell lysates and other biological fluids.

Human Exosome Component 2 (EXOSC2) ELISA Kit

4-SEH822Hu
  • EUR 5738.40
  • EUR 3031.20
  • EUR 768.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Exosome Component 2 (EXOSC2) in samples from Tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.

Human Exosome Component 2 (EXOSC2) ELISA Kit

RDR-EXOSC2-Hu-48Tests 48 Tests
EUR 652.8

Human Exosome Component 2 (EXOSC2) ELISA Kit

RDR-EXOSC2-Hu-96Tests 96 Tests
EUR 907.2

Human Exosome Component 2 ELISA Kit (EXOSC2)

RK01330 96 Tests
EUR 625.2

Human Exosome Component 2(EXOSC2)ELISA Kit

QY-E01130 96T
EUR 433.2

Human Exosome Component 2 (EXOSC2) ELISA Kit

RD-EXOSC2-Hu-48Tests 48 Tests
EUR 625.2

Human Exosome Component 2 (EXOSC2) ELISA Kit

RD-EXOSC2-Hu-96Tests 96 Tests
EUR 867.6

Human Exosome Component 2 (EXOSC2)ELISA Kit

YLA3329HU-48T 48T
EUR 435

Human Exosome Component 2 (EXOSC2)ELISA Kit

YLA3329HU-96T 96T
EUR 562.5

Exosome precipitation Solution

EPStep 12 ml
EUR 333

Lyophilized Exosome Standards

ExoA375 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoHT29 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoMCF7 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoPC3 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoPLASMA 100 μg
EUR 364.2

Lyophilized Exosome Standards

ExoUrine 100 μg
EUR 364.2

Recombinant TMPRSS2 Protein, Partial

E80017
  • EUR 423.50
  • EUR 660.00
  • EUR 2321.00
  • 20 ul
  • 100 ul
  • 1 ml

Recombinant Novel Coronavirus Spike Glycoprotein(S), Partial

E80018
  • EUR 388.30
  • EUR 860.20
  • EUR 4888.40
  • 20 ul
  • 100 ul
  • 1 ml

2-Methoxyestradiol (2-MeOE2)

27762-2 100 mg
EUR 230
Description: 2-Methoxyestradiol (2-MeOE2), an endogenous metabolite of 17β-estradiol (E2), is an inhibitor of microtubule assembly that inhibits the polymerization of tubulin and interferes with mitotic spindle dynamics leading to the blockage of mitosis of human cancer cells which lack estrogen receptors in metaphase. 2-MeOE2 is also an inhibitor of tumor growth and angiogenesis. Study results have shown that 2-MeOE2 induces mammalian cell transformation and genotoxicity in Syrian hamster embryo (SHE) fibroblasts through concentration-dependent inhibition of cell growth. Moreover, 2-MeOE2 has demonstrated anti-proliferative activity against estrogen-responsive breast cancer cell line MCF-7 and subsequent inhibition of the growth of tumors subcutaneously inoculated in mice.

ELISA kit for Human EXOSC2 (Exosome Component 2)

ELK4639 1 plate of 96 wells
EUR 518.4
Description: A sandwich ELISA kit for detection of Exosome Component 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Exosome Component 2 (EXOSC2) Polyclonal Antibody (Human), APC

4-PAH822Hu01-APC
  • EUR 414.00
  • EUR 3930.00
  • EUR 1094.40
  • EUR 528.00
  • EUR 262.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Exosome Component 2 (EXOSC2). This antibody is labeled with APC.

Exosome Component 2 (EXOSC2) Polyclonal Antibody (Human), Biotinylated

4-PAH822Hu01-Biotin
  • EUR 373.20
  • EUR 2952.00
  • EUR 872.40
  • EUR 457.20
  • EUR 262.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Exosome Component 2 (EXOSC2). This antibody is labeled with Biotin.

Exosome Component 2 (EXOSC2) Polyclonal Antibody (Human), Cy3

4-PAH822Hu01-Cy3
  • EUR 502.80
  • EUR 5190.00
  • EUR 1410.00
  • EUR 654.00
  • EUR 301.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Exosome Component 2 (EXOSC2). This antibody is labeled with Cy3.

Exosome Component 2 (EXOSC2) Polyclonal Antibody (Human), FITC

4-PAH822Hu01-FITC
  • EUR 355.20
  • EUR 3168.00
  • EUR 900.00
  • EUR 446.40
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Exosome Component 2 (EXOSC2). This antibody is labeled with FITC.

Exosome Component 2 (EXOSC2) Polyclonal Antibody (Human), HRP

4-PAH822Hu01-HRP
  • EUR 379.20
  • EUR 3426.00
  • EUR 968.40
  • EUR 477.60
  • EUR 247.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Exosome Component 2 (EXOSC2). This antibody is labeled with HRP.

Exosome Component 2 (EXOSC2) Polyclonal Antibody (Human), PE

4-PAH822Hu01-PE
  • EUR 355.20
  • EUR 3168.00
  • EUR 900.00
  • EUR 446.40
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Exosome Component 2 (EXOSC2). This antibody is labeled with PE.

XStamp IL2 exosome IL-2 receptor targeting lentivector

XSTP726PA-1 10 ug
EUR 991.2

Exosome Component 9 Peptide

46-967P 0.1 mg
EUR 405.6
Description: (CT) PMSCL1 Peptide

Exosome Component 3 Protein

20-abx263422
  • EUR 276.00
  • EUR 1930.80
  • EUR 393.60
  • 1 µg
  • 50 ug
  • 5 ug

Exosome Component 1 Protein

20-abx263423
  • EUR 1930.80
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 10 ug
  • 2 µg

Exosome Component 5 Protein

20-abx260873
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 25 ug
  • 5 ug

Exosome Component 7 Protein

20-abx261347
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Exosome Component 10 Protein

20-abx261805
  • EUR 5238.00
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Exosome Component 4 Protein

20-abx261954
  • EUR 5388.00
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Exosome Component 9 Protein

20-abx262123
  • EUR 393.60
  • EUR 6106.80
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Exosome Component 8 Protein

20-abx262850
  • EUR 393.60
  • EUR 7676.40
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

 

, , , , , , , , , , , , , ,

Post navigation

Leave a Reply

Your email address will not be published. Required fields are marked *